RMTI as of Oct 31 · 13:30 ET
RMTINasdaqPharmaceutical Preparations

Rockwell Medical, Inc. · Brief

Next report

11 days

Nov 11 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26—▲+4.19%—
quarterimplied−5%0+5%realized×
Q2 FY26—▲+4.19%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

7disclosed supplier and customer ties in SEC filingsSEC filings
34managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 4

16.00%share of revenue from the largest disclosed customer, DaVita, Inc.SEC filings
8managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

RMTI report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.